Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lena A. Wurmthaler"'
Autor:
Philipp Ziegler, Andreas D. Hartkopf, Markus Wallwiener, Lothar Häberle, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Johannes Ettl, Diana Lüftner, Volkmar Müller, Laura L. Michel, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Hanna Huebner, Sabrina Uhrig, Lena A. Wurmthaler, Carolin C. Hack, Christoph Mundhenke, Christian Kurbacher, Peter A. Fasching, Rachel Wuerstlein, Michael Untch, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Tanja N. Fehm, Andreas Schneeweiss, Chloë Goossens
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Although adequate physical activity has been shown to be beneficial in early breast cancer, evidence in metastatic breast cancer is sparse and contradictory, which could be related to distinct effects of physical activity on the d
Externí odkaz:
https://doaj.org/article/f6addaf5728b4463afe3407a59ff7008
Autor:
Peter A. Fasching, Chunling Hu, Steven N. Hart, Matthias Ruebner, Eric C. Polley, Rohan D. Gnanaolivu, Andreas D. Hartkopf, Hanna Huebner, Wolfgang Janni, Peyman Hadji, Hans Tesch, Sabrina Uhrig, Johannes Ettl, Michael P. Lux, Diana Lüftner, Markus Wallwiener, Lena A. Wurmthaler, Chloë Goossens, Volkmar Müller, Matthias W. Beckmann, Alexander Hein, Daniel Anetsberger, Erik Belleville, Pauline Wimberger, Michael Untch, Arif B. Ekici, Hans-Christian Kolberg, Arndt Hartmann, Florin-Andrei Taran, Tanja N. Fehm, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Lothar Häberle, Fergus J. Couch
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Germline mutations in BRCA1 and BRCA2 (gBRCA1/2) are required for a PARP inhibitor therapy in patients with HER2-negative (HER2−) advanced breast cancer (aBC). However, little is known about the prognostic impact of gBRCA1/2 mutations in a
Externí odkaz:
https://doaj.org/article/7fc65e7d8ec9445caafcbb4945b9c522
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-8 (2019)
Tools for conditional induction of gene expression in C. elegans are limited compared to other organisms. Here the authors present a tetracycline-dependent ribozyme that allows conditional control of a gene of interest.
Externí odkaz:
https://doaj.org/article/8715039c77e14ffeb8676a68d216cc95
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-8 (2016)
Twister ribozymes are small endonucleolytic RNA motifs. Here the authors develop twister ribozymes into RNA logic gates and cross-species synthetic genetic regulators.
Externí odkaz:
https://doaj.org/article/28d9a683e65e43fc90672e75abc33377
Autor:
Alexander, Hein, Sven, Kehl, Lothar, Häberle, Carsten, Tiemann, Rebecca, Peuker, Denise, Mereutanu, Florian M, Stumpfe, Florian, Faschingbauer, Kirstin, Meyer-Schlinkmann, Martin C, Koch, Franz, Kainer, Ulf, Dammer, Hanna, Philipp, Carolin, Kladt, Michael G, Schrauder, Stefan, Weingärtler, Volker, Hanf, Arndt, Hartmann, Matthias, Rübner, Holm, Schneider, Jos, Lelieveld, Matthias W, Beckmann, Lena A, Wurmthaler, Peter A, Fasching, Michael O, Schneider
Publikováno v:
Geburtshilfe und Frauenheilkunde. 82:226-234
Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected
Autor:
Elmar Stickeler, Bahriye Aktas, Annika Behrens, Erik Belleville, Nina Ditsch, Peter A. Fasching, Tanja N. Fehm, Andreas D. Hartkopf, Christian Jackisch, Wolfgang Janni, Cornelia Kolberg-Liedtke, Hans-Christian Kolberg, Diana Lüftner, Michael P. Lux, Volkmar Müller, Andreas Schneeweiss, Florian Schütz, Carla E. Schulmeyer, Hans Tesch, Christoph Thomssen, Christoph Uleer, Michael Untch, Manfred Welslau, Achim Wöckel, Lena A. Wurmthaler, Rachel Würstlein, Marc Thill
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 18:377-390
ZusammenfassungIn dieser Übersichtsarbeit werden nicht nur die neuesten Erkenntnisse zur Prävention, sondern auch die aktuellen Arbeiten zur Behandlung von Mammakarzinompatientinnen im frühen Krankheitsstadium zusammengefasst. In den letzten Jahre
Autor:
Matthias W. Beckmann, Lothar Häberle, Christoph Thomssen, Michael P. Lux, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Peyman Hadji, Tanja Fehm, Bernhard Volz, Erik Belleville, Alexander Hein, Wolfgang Janni, Hans Tesch, Andreas Schneeweiss, Lena A. Wurmthaler, Christian M. Kurbacher, Johannes Ettl, Carsten Hielscher, Florin-Andrei Taran, Volkmar Müller, Andreas D. Hartkopf, P Wimberger, Sara Y. Brucker, Hans-Christian Kolberg, Diana Lüftner, Diethelm Wallwiener, Peter A. Fasching, Julius Emons, Markus Wallwiener
Publikováno v:
European Journal of Cancer. 155:1-12
Purpose Assessment of HER2 overexpression using immunohistochemistry (IHC) and/or in situ hybridisation (ISH) for the detection of HER2 amplifications is standard to identify patients for established HER2-directed treatments. Patients with lower HER2
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-8 (2019)
Nature Communications
Nature Communications
The nematode Caenorhabditis elegans represents an important research model. Convenient methods for conditional induction of gene expression in this organism are not available. Here we describe tetracycline-dependent ribozymes as versatile RNA-based g
Autor:
Andreas D. Hartkopf, Manfred Welslau, Rachel Würstlein, Lena A. Wurmthaler, Bahriye Aktas, Michael P. Lux, Tanja Fehm, Christoph Uleer, Andreas Schneeweiss, Wolfgang Janni, Christian Jackisch, Florian Schütz, Elmar Stickeler, Hans Tesch, Diana Lüftner, Erik Belleville, Marc Thill, Achim Wöckel, Michael Untch, Peter A. Fasching, Carla E. Schulmeyer, Cornelia Kolberg-Liedtke, Nina Ditsch, Volkmar Müller, Annika Behrens, Hans-Christian Kolberg, Christoph Thomssen
Publikováno v:
Geburtshilfe und Frauenheilkunde
Geburtshilfe und Frauenheilkunde 81(5), 526-538 (2021). doi:10.1055/a-1464-0953
Geburtshilfe und Frauenheilkunde 81(5), 526-538 (2021). doi:10.1055/a-1464-0953
Geburtshilfe und Frauenheilkunde 81(5), 526-538 (2021). doi:10.1055/a-1464-0953
Published by Thieme, Stuttgart
Published by Thieme, Stuttgart
Autor:
Volkmar Müller, Alexander Hein, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Matthias W. Beckmann, Andreas Schneeweiss, Erik Belleville, Sabrina Uhrig, Pauline Wimberger, Carsten Hielscher, Julia Meyer, Lena A. Wurmthaler, Christian M. Kurbacher, Rachel Wuerstlein, Michael Untch, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Tanja N. Fehm, Laura L. Michel
Publikováno v:
European journal of cancer (Oxford, England : 1990). 172
Patients with de novo metastatic breast cancer (dnMBC) may have different clinical and pathological characteristics. In studies concerned with first-line metastatic patients, the proportion of these patients without secondary resistance mechanisms ma